BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17992095)

  • 21. Small molecule inhibitors in children with malignant gliomas.
    Herrington B; Kieran MW
    Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel therapies for malignant gliomas.
    Cavaliere R; Wen PY; Schiff D
    Neurol Clin; 2007 Nov; 25(4):1141-71, x. PubMed ID: 17964029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editorial review: targets for glioma treatment: from bench to bedside.
    Sanson M
    Curr Opin Oncol; 2008 Nov; 20(6):650-1. PubMed ID: 18841046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for malignant gliomas.
    Kreisl TN
    Semin Radiat Oncol; 2009 Jul; 19(3):150-4. PubMed ID: 19464629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy in the treatment of malignant gliomas.
    Stern JI; Raizer JJ
    Expert Rev Anticancer Ther; 2006 May; 6(5):755-67. PubMed ID: 16759165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing paradigms--an update on the multidisciplinary management of malignant glioma.
    Stupp R; Hegi ME; van den Bent MJ; Mason WP; Weller M; Mirimanoff RO; Cairncross JG; ;
    Oncologist; 2006 Feb; 11(2):165-80. PubMed ID: 16476837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invited article: the expanding impact of molecular biology on the diagnosis and treatment of gliomas.
    Mason WP; Cairncross JG
    Neurology; 2008 Jul; 71(5):365-73. PubMed ID: 18663182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant astrocytic glioma: genetics, biology, and paths to treatment.
    Furnari FB; Fenton T; Bachoo RM; Mukasa A; Stommel JM; Stegh A; Hahn WC; Ligon KL; Louis DN; Brennan C; Chin L; DePinho RA; Cavenee WK
    Genes Dev; 2007 Nov; 21(21):2683-710. PubMed ID: 17974913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does chemotherapy benefit the patient with a central nervous system glioma?
    Rodriguez LA; Levin VA
    Oncology (Williston Park); 1987 Nov; 1(9):29-36, 40-1. PubMed ID: 3079493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
    Brandes AA; Franceschi E; Tosoni A; Hegi ME; Stupp R
    Clin Cancer Res; 2008 Feb; 14(4):957-60. PubMed ID: 18281526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathways triggering glioma cell invasion.
    Salhia B; Tran NL; Symons M; Winkles JA; Rutka JT; Berens ME
    Expert Rev Mol Diagn; 2006 Jul; 6(4):613-26. PubMed ID: 16824034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of malignant gliomas: radiotherapy, chemotherapy and integration of new targeted agents.
    Nieder C; Grosu AL; Mehta MP; Andratschke N; Molls M
    Expert Rev Neurother; 2004 Jul; 4(4):691-703. PubMed ID: 15853588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular biology of human gliomas.
    Bansal K; Liang ML; Rutka JT
    Technol Cancer Res Treat; 2006 Jun; 5(3):185-94. PubMed ID: 16700615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.
    da Fonseca CO; Landeiro JA; Clark SS; Quirico-Santos T; da Costa Carvalho Mda G; Gattass CR
    Surg Neurol; 2006; 65 Suppl 1():S1:2-1:8; discussion S1:8-1:9. PubMed ID: 16427438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenges and the promise of molecular targeted therapy in malignant gliomas.
    Wang H; Xu T; Jiang Y; Xu H; Yan Y; Fu D; Chen J
    Neoplasia; 2015 Mar; 17(3):239-55. PubMed ID: 25810009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic therapy in brain tumors.
    Lakka SS; Rao JS
    Expert Rev Neurother; 2008 Oct; 8(10):1457-73. PubMed ID: 18928341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging drugs for malignant glioma.
    Mason WP
    Expert Opin Emerg Drugs; 2008 Mar; 13(1):81-94. PubMed ID: 18321150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel approaches to glioma drug design and drug screening.
    Patil SA; Hosni-Ahmed A; Jones TS; Patil R; Pfeffer LM; Miller DD
    Expert Opin Drug Discov; 2013 Sep; 8(9):1135-51. PubMed ID: 23738794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glial tumors--new approaches in chemotherapy.
    Armstrong TS; Gilbert MR
    J Neurosci Nurs; 2002 Dec; 34(6):326-30. PubMed ID: 12506816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.